Floatz logo

229 assets in Metastatic Prostate Carcinoma

Therapeutic assets addressing Metastatic Prostate Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bortezomib
Metastatic Prostate Carcinoma
University of UtahP2CCC (48)
Ceralasertib
Metastatic Prostate Carcinoma
Rahul AggarwalP2CCC (48)
Datopotamab Deruxtecan
Metastatic Prostate Carcinoma
AstraZenecaP2CCC (48)
Disitamab Vedotin
Metastatic Prostate Carcinoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (48)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Metastatic Prostate Carcinoma
University of UtahP2CCC (48)
Etrumadenant
Metastatic Prostate Carcinoma
Catherine SpinaP2CCC (48)
fg-3246
Metastatic Prostate Carcinoma
Kyntra BioP2CCC (48)
Fluzoparib
Metastatic Prostate Carcinoma
Jianbin BiP2CCC (48)
Fpi-2265
Metastatic Prostate Carcinoma
Fusion Pharmaceuticals Inc.P2CCC (48)
Inavolisib
Metastatic Prostate Carcinoma
Hoffmann-La RocheP2CCC (48)
Lutetium-Psma
Metastatic Prostate Carcinoma
Medical University of ViennaP2CCC (48)
Pamiparib
Metastatic Prostate Carcinoma
The First Affiliated Hospital of Xiamen UniversityP2CCC (48)
Rilvegostomig
Metastatic Prostate Carcinoma
AstraZenecaP2CCC (48)
rs-113,
Metastatic Prostate Carcinoma
R-Pharm International, LLCP2CCC (48)
srf617
Metastatic Prostate Carcinoma
Coherus Oncology, Inc.P2CCC (48)
Tazemetostat
Metastatic Prostate Carcinoma
Dana-Farber Cancer InstituteP1/2CCC (48)
Volrustomig
Metastatic Prostate Carcinoma
AstraZenecaP2CCC (48)
xnw5004
Metastatic Prostate Carcinoma
Evopoint Biosciences Inc.P1/2CCC (48)
Zenocutuzumab
Metastatic Prostate Carcinoma
Partner Therapeutics, Inc.P2CCC (48)
Zimberelimab
Metastatic Prostate Carcinoma
Catherine SpinaP2CCC (48)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01
Metastatic Prostate Carcinoma
Kidney Cancer Research BureauP1/2CC (47)
Ivuxolimab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (47)
Sumarotene
Metastatic Prostate Carcinoma
CuraCell TX ABP1/2CC (47)
Uromitexan
Metastatic Prostate Carcinoma
CuraCell TX ABP1/2CC (47)
177Lu-rhPSMA-10.1
Metastatic Prostate Carcinoma
Blue Earth Therapeutics LtdP1/2CC (46)
[68ga]ga-oncoacp3
Metastatic Prostate Carcinoma
Philogen S.p.A.P1CC (46)
Fulvestrant
Metastatic Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (46)
Utomilumab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (46)
68ga-p15-041
Metastatic Prostate Carcinoma
Peking Union Medical College HospitalP1/2CC (45)
Arv 766
Metastatic Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (45)
HB-301
Metastatic Prostate Carcinoma
Hookipa Biotech GmbHP1/2CC (45)
HB-302
Metastatic Prostate Carcinoma
Hookipa Biotech GmbHP1/2CC (45)
Midazolam
Metastatic Prostate Carcinoma
Orion Corporation, Orion PharmaP1/2CC (45)
Asidna
Metastatic Prostate Carcinoma
Valerio TherapeuticsP1/2CC (44)
Inkmune
Metastatic Prostate Carcinoma
Inmune Bio, Inc.P1/2CC (44)
11C-YJH08
Metastatic Prostate Carcinoma
Rahul AggarwalP1CC (43)
Autologous Anti-Psca-Car-4-1Bb/Tcrzeta-Cd19T-Expressing T-Lymphocytes
Metastatic Prostate Carcinoma
City of Hope Medical CenterP1CC (43)
azd0516
Metastatic Prostate Carcinoma
AstraZenecaP1/2CC (43)
azd0754
Metastatic Prostate Carcinoma
AstraZenecaP1/2CC (43)
azd8359
Metastatic Prostate Carcinoma
AstraZenecaP1/2CC (43)
Balstilimab
Metastatic Prostate Carcinoma
ImmunoGenesisP1/2CC (43)
Evofosfamide
Metastatic Prostate Carcinoma
ImmunoGenesisP1/2CC (43)
Fapi-46
Metastatic Prostate Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Gdc-1261
Metastatic Prostate Carcinoma
Genentech, Inc.P1/2CC (43)
Hld-0915
Metastatic Prostate Carcinoma
Halda Therapeutics OpCo, Inc.P1/2CC (43)
op-3136
Metastatic Prostate Carcinoma
Olema Pharmaceuticals, Inc.P1CC (43)
Palacaparib
Metastatic Prostate Carcinoma
AstraZenecaP1/2CC (43)
Palazestrant
Metastatic Prostate Carcinoma
Olema Pharmaceuticals, Inc.P1CC (43)
st101
Metastatic Prostate Carcinoma
Sapience TherapeuticsP1/2CC (43)
Tcrzeta-Cd19T-Expressing T-Lymphocytes
Metastatic Prostate Carcinoma
City of Hope Medical CenterP1CC (43)
Showing 101 to 150 of 229 assets
PreviousPage 3 of 5Next